AnserBio is an Israeli biomedical startup developing a novel approach to cancer treatment. Our unique method of healthy p53 protein delivery into tumor cells is expected to benefit treatment of more than 60% of human cancers - alone or in combination with other agents. The company is in preclinical stage.
| Website | https://www.anser-bio.com/ |
| Employees | 9 (5 on RocketReach) |
| Founded | 2017 |
| Industry | Biotechnology Research |
Looking for a particular AnserBio employee's phone or email?
AnserBio Questions
5 people are employed at AnserBio.
Top AnserBio Employees
G2Crowd Trusted
300K+
Plugin Users
